Insights from 2023 ASCO® Annual Meeting
H

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNBC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Hyo Han
June 8, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

13:03
Novartis Oncology

CDK4/6 Inhibitor Option for HR+/HER2- mBC: Are All CDK4/6 Inhibitors…

Feat. D. Slamon

Featured Video

18:15
Novartis Oncology

CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…

Feat. G. Hortobagyi

Related Content

AUTOPLAY
28:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
17:39
Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin
04:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney
24:36
ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
20:42
Total Health

2022 Updates in TNBC

Feat. I. Schlam
53:42
PleXus Communications

Managing Woman's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
03:05
ecancer

ASCO® 2023 Insights: "Phase III NATALEE Trial - Ribociclib + ET…

Feat. D. Slamon
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Utility of Ki67 in Guiding Adjuvant Abema…

Feat. R. Patel
18:49
Yale School of Medicine

Menopause and Hot Flashes: What Medications are Available?

Feat. M. Minkin
22:29
ESMO 2022 Conference Coverage

ESMO 2022 on Adjuvant Endocrine Therapy for BC: Who Needs More Than …

Feat. E. de Azambuja
03:32
UCSF School of Medicine

Management of Abemaciclib-Related Diarrhea in HR+/HER2- eBC

Feat. S. Donahue
26:28
2023 West Oncology Conference

Antibody Drug Conjugates for Breast Cancer: The End of Chemotherapy?

Feat. L. Schwartzberg
12:02
SABCS 2022 Conference Coverage

SABCS 2022 10-Year Results of a Phase 3 Trial of Low-Dose Tamoxifen …

Feat. A. De Censi
08:41
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III…

Feat. P. Conte
10:54
Yale Cancer Center

De-Escalation of Adjuvant Therapy in Early Stage HER2+ Breast Cancers

Feat. L. Pusztai
10:19
ASCO 2022 Conference Coverage

ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on …

Feat. M. Tesch
07:49
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

Feat. H. Rugo
10:22
ESMO 2022 Conference Coverage

ESMO 2022 Updates on mTNBC

Feat. L. Carey